Trial Search Results

Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management

The ability to predict pain and then apply modified treatment protocols has been limited. Current practice is for physicians to select standard post-operative pain treatment protocols without patient consultation. This study hopes to determine if patient's involvement in analgesic drug/dosage selection can optimize pain relief while minimizing related side effects. This could result in a more patient-centered care model and individualized perioperative analgesic treatment protocols based on patient's preferences, needs and expectations.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Other: No choice given
  • Other: Choice given
  • Drug: Ibuprofen
  • Drug: Acetaminophen
  • Drug: Gabapentin
  • Drug: Morphine (low)
  • Drug: Morphine (med)
  • Drug: Morphine (high)




Inclusion Criteria:

   - Women age 18-50

   - Singleton gestation

   - Not in active labor

   - Scheduled for their 1st, 2nd, or 3rd elective Cesarean

   - Cesarean deliveries under spinal or combined spinal epidural anesthesia (with no
   additional epidural doses administered)

Exclusion Criteria:

   - History of chronic pain, anxiety, or depression

   - Unable to understand the concept of Verbal Numerical Pain Scale at the time of
   informed consent

   - Chronic consumption of opiates, antidepressants or anticonvulsants

   - Intake of opioids, NSAIDS or acetaminophen 48hrs prior to the psychophysical test

   - Preeclampsia (with any severe features)

   - Diabetes (not controlled with diet and needing drugs)

   - Preterm delivery (<35 weeks gestation)

Ages Eligible for Study

18 Years - 50 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Brendan Carvalho, MBBCh, MDCH
(650) 724-2614
Not Recruiting